Japan stocks set to trade lower as investors monitor coronavirus developments

The Food and Drug Administration approved Gilead Sciences' antiviral drug remdesivir for the virus. The intravenous drug has helped shorten the recovery time of some hospitalized Covid-19 patients.

from Asia News https://ift.tt/31yR776